These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9690957)

  • 1. Risk of gastrointestinal haemorrhage with calcium antagonists.
    Desboeuf K; Lapeyre-Mestre M; Montastruc JL
    Br J Clin Pharmacol; 1998 Jul; 46(1):88-9. PubMed ID: 9690957
    [No Abstract]   [Full Text] [Related]  

  • 2. [Calcium inhibiting drugs and the risk of gastrointestinal hemorrhage. A pharmaco-epidemiologic case-non-case study].
    Desboeuf K; Lapeyre-Mestre M; Montastruc JL
    Arch Mal Coeur Vaiss; 1999 Aug; 92(8):1095-9. PubMed ID: 10486672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The safety of Calcium channel blockers].
    Leinonen H
    Duodecim; 1996; 112(21):1961-2. PubMed ID: 10605196
    [No Abstract]   [Full Text] [Related]  

  • 4. [Calcium antagonists and hypertension: in search of absolute certainty].
    Mayer G
    Wien Klin Wochenschr; 1998 Oct; 110(18):621-4. PubMed ID: 9816633
    [No Abstract]   [Full Text] [Related]  

  • 5. Major upper gastrointestinal bleeding and the use of calcium channel blockers.
    Kelly JP; Laszlo A; Kaufman DW; Sundstrom A; Shapiro S
    Lancet; 1999 Feb; 353(9152):559. PubMed ID: 10028991
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of calcium antagonists and hemoglobin loss in hospitalized elderly patients: a cohort study. Gruppo Italiano di Farmacoepidemiologia nell'Anziano (GIFA) investigators.
    Zuccalà G; Pedone C; Cocchi A; Pahor M; Carosella L; Carbonin P; Bernabei R
    Clin Pharmacol Ther; 2000 Mar; 67(3):314-22. PubMed ID: 10741636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists and gastrointestinal haemorrhage: the balancing act.
    Gordon RD
    Lancet; 1996 Apr; 347(9008):1056. PubMed ID: 8602049
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of calcium antagonists--a question for the SBU].
    Philip-Shansky A; Higham P
    Lakartidningen; 1995 Nov; 92(44):4076. PubMed ID: 8538266
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcium antagonists: a scandal in need of an inquiry.
    Jackson G
    Int J Clin Pract; 2003; 57(6):455. PubMed ID: 12918880
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
    Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do calcium antagonists cause death, gastrointestinal bleeding, and cancer?
    Kaplan NM
    Am J Cardiol; 1996 Oct; 78(8):932-3. PubMed ID: 8888668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism to calcium antagonists.
    Psaty BM; Sevick MA
    Lancet; 1996 Jun; 347(9017):1761. PubMed ID: 8656916
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tocolysis with calcium-channel blockers and intraventricular hemorrhage].
    Nguon B; Zupan-Simunek V; Audibert F; Preaux N
    J Gynecol Obstet Biol Reprod (Paris); 2007 May; 36(3):287-92. PubMed ID: 17395401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium channel blockers and gastrointestinal hemorrhage: more bad press?
    Grimm I; Shaheen N
    Gastroenterology; 1996 Nov; 111(5):1391-3. PubMed ID: 8898658
    [No Abstract]   [Full Text] [Related]  

  • 15. Antagonism to calcium antagonists.
    Pilotto A; Leandro G; Franceschi M; Di Mario F; Valerio G
    Lancet; 1996 Jun; 347(9017):1761-2. PubMed ID: 8656917
    [No Abstract]   [Full Text] [Related]  

  • 16. Antagonism to calcium antagonists.
    Lip GY; Beevers DG
    Lancet; 1996 Jun; 347(9017):1761. PubMed ID: 8656915
    [No Abstract]   [Full Text] [Related]  

  • 17. Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage.
    van Soest EM; Sturkenboom MC; Dieleman JP; Verhamme KM; Siersema PD; Kuipers EJ
    Aliment Pharmacol Ther; 2007 Jul; 26(2):265-75. PubMed ID: 17593072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers.
    Sørensen HT; Czeizel AE; Rockenbauer M; Steffensen FH; Olsen J
    Acta Obstet Gynecol Scand; 2001 May; 80(5):397-401. PubMed ID: 11328214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purpura and bleeding due to calcium-channel blockers: an underestimated problem? Case reports and a pilot study.
    Cox NH; Walsh ML; Robson RH
    Clin Exp Dermatol; 2009 Jun; 34(4):487-91. PubMed ID: 19094124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.